Next-Gen Biomaterials: From Scientific Breakthrough to Scalable Value Creation

Healthcare is entering a new era where the focus is shifting from treating disease to restoring function, accelerating healing, and improving long-term patient outcomes. At the heart of this transformation are next-generation biomaterials, the foundation of smarter implants, regenerative therapies, precision drug delivery, and advanced medical devices.

The need has never been greater. The World Health Organization estimates that by 2030, one in six people globally will be over the age of 60, driving a significant rise in age-related conditions requiring advanced therapeutic interventions. Meanwhile, more than 1.3 million hip and knee replacement procedures are performed annually in the United States, underscoring the growing reliance on high-performance biomaterials that improve implant longevity, tissue integration, and patient recovery.

Advances in bioactive materials, bioresorbable polymers, smart biomaterials, nanostructured materials, tissue-engineered scaffolds, and 3D-printed implants are rapidly moving from laboratory research to commercial healthcare applications. These innovations are enabling more personalized treatments, reducing complications, and redefining standards of care across orthopedics, cardiovascular interventions, wound healing, ophthalmology, dental care, and regenerative medicine.

This on-demand webinar brings together industry experts to examine the technologies driving this transformation, the market forces accelerating adoption, and the opportunities shaping the future of biomaterials across the healthcare ecosystem.

From this webinar you’ll gain insights into:

• A strategic understanding of why biomaterials have become a critical enabler of next-generation healthcare, supporting better patient outcomes, faster recovery, and longer-lasting therapies.
• Insights into the breakthrough technologies moving toward commercialization, including smart biomaterials, bioresorbable polymers, bioactive materials, tissue-engineered scaffolds, nanomaterials, and 3D-printed medical implants.
• A comprehensive view of the therapeutic areas creating the greatest value today, spanning orthopedics, cardiovascular care, wound management, ophthalmology, dental applications, regenerative medicine, and targeted drug delivery.
• An executive perspective on the evolving biomaterials ecosystem, including the role of MedTech companies, advanced materials innovators, research institutions, healthcare providers, and strategic collaborations in accelerating innovation.
• A market-focused outlook on the trends influencing investment and adoption, from aging populations and chronic disease prevalence to personalized medicine, minimally invasive procedures, sustainability, and regulatory evolution.
• Actionable insights to help identify where the next wave of opportunity lies, enabling R&D, innovation, product, clinical, and strategy leaders to evaluate technologies, partnerships, and business models with the highest potential for long-term impact.

If you are a R&D leader, innovation manager, product development team member, materials scientist, MedTech executive, biotech professional, healthcare strategist, clinician, and business leader looking to understand where biomaterials are creating measurable value today and where the next generation of healthcare innovation is headed, then this webinar is for you.